National and Kapodistrian University of Athens
Συσχέτιση της απορρύθμισης των γονιδίων HER2/NEU και PTEN με τη βιολογική συμπεριφορά του αδενοκαρκινώματος του παχέος εντέρου
Abstract
dc:descriptionPurpose: The deregulation of the mollecullar signal transduction pathways to the core is subject of investigation for the mechanism of tumorigenesis and development of cancer. HER-2/NEU protein has an important part in PI3K/ Akt/m TOR signaling pathway with the activation of the Src/SH2 proteins, whom is competing the action of PTEN((lipid Phosphatase and TENsin homologue) maintaining the balance at the signal transduction pathway to the core. Our aim was to investigate correlation between HER2 and PTEN protein levels , the Her gene/Chr17 copies and their correlation with clinical data of colon cancer.Methοds: Sixty (n=60) paraffin-embedded primary CAs were cored at 1,5 mm diameter and transferred to the microarray block. Immunohistochemistry (IHC) was performed using anti-HER2 monoclonal antibody and anti-Pten polyclonal antibody. Chromogenic in situ hybridization (CISH) was performed using HER2 gene/ chromosome 17 centromeric probes. Results:At IHC, HER2 protein overexpression (score: 2+/3+) was observed in 20/60 (33.3%) and loss or low expression of PTEN protein was observed in 34/60(56,6%) cases. CISH analysis detected 11/60 (18.33%) amplified cases, whereas chromosome 17 aneuploidy (polysomy) was identified in 13/60 (21.66%) cases. Significant associations raised correlating HER2 expression to grade of the tumours (p=0.03), Chr 17 to stage (p=0.001), gene copies to protein expression (p=0.008), and also Chr 17 centromere signals to overall gene signals (p=0.001). Finally there was significant correlation of HER2 protein expresion and PTEN(P=0,002) Conclusion: Multiple HER2 gene copies lead to different protein expression patterns (score 1+ to 3+) but pure gene amplification is only a sub set of them. Identification of chromosome polysomy is a critical parameter in detecting original gene amplification in conventional one-colour CISH methods. In addition loss or low levels of PTEN protein in combination with the overexpression of HER2 protein(2+/3+) with mechanisms like gene amplification, is an important element in a possible management of a patient subset for the application of target therapy.
Degree
thesis:*- Grantor dc:publisher
- National and Kapodistrian University of Athens
- Year dc:date
- 2014
Author and committee
dc:creator, dc:contributor.*- Authors dc:creator
-
- Fotiadis, Panagiotis
- Φωτιάδης, Παναγιώτης
Subjects
dc:subject × 16- Γονίδια
- Αδενοκαρκίνωμα παχέος εντέρου
- Ανοσοϊστοχημεία
- Χρωμογόνος in situ υβριδισμός
- Genes
- HER2
- PTEN
- Colon cancer
- Immunohistochemistry
- Chromogenic in situ hybridization
- Ιατρική και Επιστήμες Υγείας
- Επιστήμες Υγείας
- Ιατρική Βιοτεχνολογία
- Medical and Health Sciences
- Health Sciences
- Medical Biotechnology
Rights
- Language dc:language
- gre
Identifiers
dc:identifier.*- Identifier
- 10.12681/eadd/40561